Hanly Conroy Bierstein & Sheridan

Hanly Conroy Bierstein & Sheridan was a prominent New York-based law firm specializing in complex mass torts and pharmaceutical litigation. The firm was highly regarded for its work representing plaintiffs in high-stakes legal actions against major pharmaceutical manufacturers and healthcare providers. In 2014, the firm merged with Simmons Browder Gianaris Angelides & Barnerd to form Simmons Hanly Conroy, which became one of the largest plaintiff-side law firms in the United States. The firm's legacy includes leading roles in landmark litigations involving the opioid crisis, OxyContin, and various defective medical devices. Their practice focused on securing settlements and judgments for individuals harmed by corporate misconduct in the healthcare and consumer product sectors.